文献速递哮喘

全球哮喘网络I期全球监测的原理与方法:患病率、严重程度、管理与危险因素

The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
PubMed 文献 · Eur Respir J · 2017-01-11

全球哮喘网络(GAN)于2012年建立,延续国际儿童哮喘与过敏研究(ISAAC)。本文描述GAN I期方法:在ISAAC相同年龄组及其父母中收集哮喘、鼻炎、湿疹的患病率、严重程度、诊断、急诊就诊、住院、管理及基本药物使用信息,为2003年以来首次全球儿童与成人哮喘监测,旨在理解哮喘管理实践与危险因素以减轻全球负担。

要点

  • GAN I期在ISAAC相同年龄组及父母中开展哮喘全球监测。
  • 收集内容包括患病率、严重程度、诊断、急诊就诊、住院、管理与药物使用。
  • 这是2003年以来首次全球儿童与成人哮喘监测。

核心结论

  • GAN I期将在ISAAC基础上进一步收集哮喘、鼻炎和湿疹的患病率、严重程度、诊断、急诊就诊、住院、管理及基本药物使用信息,以理解哮喘管理实践和危险因素,减轻全球负担。

研究设计与样本

  • GAN于2012年建立,延续ISAAC;GAN I期受试者为与ISAAC相同的年龄组及其父母,为2003年以来首次全球儿童与成人哮喘监测。

主要发现

  • ISAAC I期纳入56个国家156个中心的超过700 000名青少年和儿童,发现哮喘、鼻炎和湿疹症状患病率全球差异显著,且无法用当前对该疾病的理解解释。
  • ISAAC III期纳入98个国家237个中心的超过1 187 496名青少年和儿童,发现许多地区哮喘症状患病率上升,尤其是低中收入国家,且严重程度也高,并识别出若干需进一步研究的环境因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Global Asthma Network (GAN), established in 2012, followed the International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Phase One involved over 700 000 adolescents and children from 156 centres in 56 countries; it found marked worldwide variation in symptom prevalence of asthma, rhinitis and eczema that was not explained by the current understanding of these diseases; ISAAC Phase Three involved over 1 187 496 adolescents and children (237 centres in 98 countries). It found that asthma symptom prevalence was increasing in many locations especially in low- and middle-income countries where severity was also high, and identified several environmental factors that required further investigation.GAN Phase I, described in this article, builds on the ISAAC findings by collecting further information on asthma, rhinitis and eczema prevalence, severity, diagnoses, asthma emergency room visits, hospital admissions, management and use of asthma essential medicines. The subjects will be the same age groups as ISAAC, and their parents. In this first global monitoring of asthma in children and adults since 2003, further evidence will be obtained to understand asthma, management practices and risk factors, leading to further recognition that asthma is an important non-communicable disease and to reduce its global burden.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Ellwood P, Asher MI, Billo NE, et al. The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors. Eur Respir J. 2017. PMID: 28077477. doi:10.1183/13993003.01605-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。